ATYR
aTyr Pharma, Inc.
0.305$
-9.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.5% | -6.1% | -6.5% | -13.5% | +5.7% | +0.4% | +4.4% | +5.0% | -11.7% | -15.4% | -12.3% | |
| – | -4.0% | -5.9% | -6.8% | -15.5% | +7.4% | +1.6% | +5.1% | +6.3% | -13.7% | -15.8% | -13.6% | |
| – | +130.3% | -69.8% | 0.0% | +68.4% | -3.5% | -6.3% | +66.2% | -64.3% | +74.7% | -6.8% | +61.5% | |
| – | -3.9% | -13.9% | -7.1% | -15.9% | +9.3% | +5.9% | +5.2% | +12.3% | -12.8% | -15.5% | -13.7% | |
| – | +16.7% | +1.6% | -34.2% | +12.5% | -5.2% | -43.1% | -49.6% | +109.2% | -16.2% | -45.4% | -10.7% | |
| – | +12.3% | -4.0% | -15.4% | +8.0% | +2.0% | -17.1% | +20.1% | -1.0% | +1.0% | -18.5% | -3.1% | |
| – | +27.4% | -2.7% | -25.9% | +19.3% | +6.0% | -28.6% | +45.4% | +0.9% | -3.4% | -22.8% | -2.6% | |
| – | +7.7% | -14.5% | +3.3% | +3.2% | +3.4% | +3.0% | +3.2% | +7.4% | +2.6% | +1.4% | -1.5% | |
| – | +72.7% | +38.7% | -74.4% | +214.7% | +9.5% | -64.6% | +153.5% | +4.7% | -4.3% | -29.2% | +17.7% | |
| – | -7.9% | -6.8% | -3.4% | -20.0% | +7.2% | +7.2% | -0.3% | +7.2% | -15.9% | -14.1% | -15.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.4% | +11.5% | +9.4% | +4.9% | +9.1% | +4.5% | +4.2% | +7.8% | +0.9% | +0.0% | +0.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.